Abstract
Objective: To analyze the clinical features of invasive pulmonary fungal infection (IPFI), and to explore the prevention and treatment of IPFI. Methods: Clinical data of 103 cases with IPFI diagnosed in our hospital were retrospectively analyzed. Results: COPD, bronchial lung cancer, and the abuse of antibiotics were the main risk factors of IPFI, among which Candida albicans accounted for 57.3% and Aspergillus species accounted for 32%in all cases. The mortality of IPFI patients was 20.4%. Conclusions: IPFI is a secondary pulmonary infection because of variety of predisposing factors, and its mortality rate is high. Early diagnosing, effective treatment for the fungus and enhancing the nutrition are good for IPFI.
Highlights
Clinical data of 103 cases with invasive pulmonary fungal infection (IPFI) diagnosed in our hospital were retrospectively analyzed
COPD, bronchial lung cancer, and the abuse of antibiotics were the main risk factors of IPFI, among which Candida albicans accounted for 57.3% and Aspergillus species accounted for 32%in all cases
Effective treatment for the fungus and enhancing the nutrition are good for IPFI
Summary
Global Journal of Public Health, 2016, Vol.3, No.2 Clinical analysis of 103 cases of invasive pulmonary fungal infection Zu-ping Zhang1, Zhi-ping Zeng2 1Qixian people's hospital of Shanxi Province, Qixian, Shanxi, China 2The 1st affiliated hospital of Gannan medical college respiratory medicine, Ganzhou, Jiangxi, China Objective: To analyze the clinical features of invasive pulmonary fungal infection (IPFI), and to explore the prevention and treatment of IPFI.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
